VistaPharm Recalls Metoclopramide Oral Solution Due to Labeling Error
VistaPharm is recalling 73,800 cups of Metoclopramide Oral Solution because the shipper label incorrectly displayed '5 mL x 50' instead of '10 mL x 50'.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, and the issue is a minor labeling error on the shipper label.
Plain-English summary
VistaPharm, Inc. is recalling 73,800 cups of Metoclopramide Oral Solution, USP 5 mg/5 mL. The product is a prescription-only liquid medication manufactured in Largo, Florida. The recall involves product with code 195900 and an expiration date of 01/12.
The recall was initiated due to a labeling error on the shipper label. The label displayed '5 mL x 50' instead of the correct '10 mL x 50'. This is a Class III recall, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
The product was distributed nationwide. Consumers and healthcare providers should check their inventory for this specific product code and expiration date. If found, the product should be returned to the supplier or disposed of according to local regulations.
The recalled product
- Product
- METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, This cup delivers 10 mL, Rx Only, Manufactured by VistaPharm, Inc., Largo FL33771
- Manufacturer
- VistaPharm, Inc.
- Category
- Drug — Oral Solution
- Hazard
- Affected units
- 73,800
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 195900 exp. 01/12.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · VistaPharm, Inc.
See all →- ModeratePrescription pyridostigmine bromide oral solution recalled for out-of-specification preservative
FDA (Drugs) · 2022-11-02
- ModerateClobazam Oral Suspension Recalled for Failed Stability Specifications
FDA (Drugs) · 2022-01-26
- LowVistaPharm Recalls Nystatin Oral Suspension Due to Impurity
FDA (Drugs) · 2020-10-14
- LowVistaPharm Recalls Nystatin Oral Suspension Due to Impurity Exceeding Specifications
FDA (Drugs) · 2020-07-15
- LowVistaPharm Recalls Nystatin Oral Suspension Due to Impurity Peak
FDA (Drugs) · 2020-07-15
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02